Select Medical Q1 revenue up 5% but net income falls 15%; equity vesting delayed for executives

Filed April 30, 2026 · Period ending April 28, 2026 · ~1 min read

Key Changes

• high

  Q1 2026 revenue rose 5.0% to $1.42B, but net income fell 14.7% to $63.8M and EPS dropped from $0.44 to $0.35 as cost of services increased 6.3% and margins compressed across most segments.

  Exhibit 99.1 verify on EDGAR →
• high

  Pending $16.50/share going-private merger with consortium led by Executive Chairman and Welsh Carson cleared HSR review on April 27; transaction expected to close mid-2026 subject to shareholder vote.

  Exhibit 99.1 verify on EDGAR →
• medium

  Board delayed vesting of 304,001 equity awards for Executive Chairman Ortenzio (190,000 shares) and SVP Jackson (114,001 shares) by one year, pushing 2026 vesting dates to 2027.

  Item 5.02 verify on EDGAR →